Pulmatrix Inc (PULM)
2.08
+0.06
(+2.97%)
USD |
NASDAQ |
Apr 25, 16:00
2.04
-0.04
(-1.92%)
Pre-Market: 20:00
Pulmatrix Cash from Financing (TTM): 0.053M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.053M |
September 30, 2023 | 0.053M |
June 30, 2023 | 1.435M |
March 31, 2023 | 1.435M |
December 31, 2022 | 1.23M |
September 30, 2022 | 7.422M |
June 30, 2022 | 6.04M |
March 31, 2022 | 6.04M |
December 31, 2021 | 43.48M |
September 30, 2021 | 37.28M |
June 30, 2021 | 50.15M |
March 31, 2021 | 58.00M |
December 31, 2020 | 20.98M |
September 30, 2020 | 20.98M |
June 30, 2020 | 8.12M |
March 31, 2020 | 14.92M |
December 31, 2019 | 17.70M |
September 30, 2019 | 20.64M |
June 30, 2019 | 20.62M |
March 31, 2019 | 17.71M |
December 31, 2018 | 15.79M |
September 30, 2018 | 13.30M |
Date | Value |
---|---|
June 30, 2018 | 13.33M |
March 31, 2018 | 5.696M |
December 31, 2017 | 13.92M |
September 30, 2017 | 12.84M |
June 30, 2017 | 12.41M |
March 31, 2017 | 8.305M |
December 31, 2016 | -1.046M |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | 0.328M |
December 31, 2014 | 17.28M |
September 30, 2014 | 17.42M |
June 30, 2014 | 18.49M |
March 31, 2014 | 18.44M |
December 31, 2013 | 1.951M |
September 30, 2013 | 1.846M |
June 30, 2013 | 0.799M |
March 31, 2013 | 0.526M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.053M
Minimum
Sep 2023
58.00M
Maximum
Mar 2021
17.72M
Average
14.92M
Median
Mar 2020
Cash from Financing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.91M |
Palatin Technologies Inc | 5.553M |
iBio Inc | 10.68M |
Theriva Biologics Inc | 0.625M |
Oragenics Inc | 0.2839M |